logo-loader
RNS
Amphion Innovations PLC

Amphion Innovations - AGM Statement

RNS Number : 8103M
Amphion Innovations PLC
01 August 2017
 

 

 

 

 

Amphion Innovations plc

 ("Amphion" or "the Company")

1 August 2017

Results of AGM

London and New York, 1 August 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that all resolutions were passed at the Annual General Meeting, which was held on Tuesday 1 August 2017. 

For further information please contact:

 

Amphion Innovations

Tel: +1 (212) 210 6224

Charlie Morgan




Panmure Gordon Limited (Nominated Adviser and Corporate Broker)

Tel: +44 (0)20 7886 2500

Freddy Crossley / Duncan Monteith (Corporate Finance)


Charlie Leigh-Pemberton (Corporate Broking)




Northland Capital Partners Limited (Joint Corporate Broker)

Tel: +44 (0)20 3861 6625

Patrick Claridge / David Hignell (Corporate Finance)


John Howes (Corporate Broking)




Walbrook PR

Tel: +44 (0)20 7933 8780 or

Mike Wort/ Paul McManus

amphion@walbrookpr.com



 

 

About Amphion Innovations plc

 

Amphion Innovations is a developer of medical, life science and technology businesses.

 

We use our extensive experience in company building to invest and build shareholder value in high growth companies in the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

 

On the web: www.amphionplc.com 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGOKDDDABKDOFK
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

Amphion Innovations hails favourable court ruling

Richard Morgan, chief executive of Amphion Innovations (LON:AMP), explains the ins and outs of the ruling it has received in a US federal court relating to its patented intellectual property. He tells Proactive Investors that the company has been striving to protect a software patent related...

on 04/14/2014

2 min read